A Systematic Review of the Reliability of Frequency-Volume Charts in Urological Research and its Implications for the Optimum Chart Duration
Wednesday, 17 January 2007
BJUI - Mini Review - January 2007 To determine how the reliability of frequency volume charts (FVCs) vary with their duration when used to assess patients with lower urinary tract symptoms (LUTS) and whether the duration influences patient compliance.
read more
|
European Urology - The Correlation between Metabolic Syndrome and Prostatic Growth in Patients with Benign Prostatic Hyperplasia
Wednesday, 10 January 2007
Volume 51, Issue 1, Pages 199-206 (January 2007) Abstract - Objectives:To evaluate the relationship between metabolic syndrome and annual prostatic growth rates in benign prostatic hyperplasia (BPH) patients.
read more
|
American Urological Association Names New Director of Guidelines
Wednesday, 03 January 2007
BALTIMORE, January 2007 — The American Urological Association (AUA) has announced that Heddy Hubbard, Ph.D., M.P.H., R.N., F.A.A.N. will be the new Director of Guidelines for the association. Dr. Hubbard joined the AUA on December 28, 2006.
read more
|
European Urology - The Efficacy of Drugs for the Treatment of LUTS/BPH, A Study in 6 European Countries
Monday, 01 January 2007
Volume 51, Issue 1, Pages 207-216 (January 2007) Abstract - Objectives: This paper profiles the usage and effectiveness of various LUTS/BPH drugs in real-life practice.
read more
|
European Urology - The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction
Monday, 01 January 2007
Volume 51, Issue 1, Pages 57-66 (January 2007) Abstract - Objectives: Benign prostatic hyperplasia (BPH) is considered a frequent cause of bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS), although the physiopathologic mechanism through which BPH causes LUTS is not clear.
read more
|
BJUI Mini Reviews - A Systematic Review of the Reliability of Frequency-Volume Charts in Urological Research and its Implications for the Optimum Chart Duration
Monday, 01 January 2007
This article reports a systematic review of studies
that assessed the reliability of FVCs, with the
aim of determining the optimum FVC
duration for assessing the voiding behaviour
of patients with LUTS.
Login to read more...
|
European Urology - Unexpected Insights into Pelvic Function Following Phosphodiesterase Manipulation—What's Next for Urology?
Friday, 22 December 2006
Volume 50, Issue 6, Pages 1153-1156 (December 2006) Article Outline: The review article concerning phosphodiesterases (PDEs) submitted by Ückert et al. is both excellent and comprehensive in its evaluation of the PDE isoenzymes and their potential role in various urologic settings [1].
read more
|
European Urology - Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
Thursday, 21 December 2006
Volume 50, Issue 6, Pages 1194-1207 (December 2006) 1. IntroductionThe cyclic nucleotide monophosphates (cNMPs) cAMP and cGMP are important intracellular regulators of several processes, including smooth muscle motility, electrolyte homeostasis, neuroendocrine signals and retinal phototransduction [1], [2].
read more
|
European Urology - Alfuzosin (10mg) Does Not Affect Blood Pressure in Young Healthy Men
Monday, 18 December 2006
Volume 50, Issue 6, Pages 1292-1298 (December 2006) Abstract - Objectives: Alfuzosin 10mg is a uroselective α1-adrenoceptor antagonist used to treat lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Recent studies have suggested the potential efficacy of alfuzosin in the treatment of distal ureteral stones and prostatitis syndrome, two conditions frequently encountered in young patients.
read more
|
European Urology - Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
Thursday, 07 December 2006
Volume 50, Issue 6, Pages 1306-1315 (December 2006) Abstract - Objective: Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions.
read more
|
BPH & Male LUTS 
